<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Vet Res Forum</journal-id><journal-id journal-id-type="iso-abbrev">Vet Res Forum</journal-id><journal-id journal-id-type="publisher-id">VRF</journal-id><journal-title-group><journal-title>Veterinary Research Forum</journal-title></journal-title-group><issn pub-type="ppub">2008-8140</issn><issn pub-type="epub">2322-3618</issn><publisher><publisher-name>Urmia University Press</publisher-name><publisher-loc>Urmia, Iran</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26893814</article-id><article-id pub-id-type="pmc">4611978</article-id><article-id pub-id-type="publisher-id">vrf-6-233</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Effects of essential oil of <italic>Satureja khuzestanica</italic> on the oxidative stress in experimental hyperthyroid male rat</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Assaei</surname><given-names>Raheleh</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Mostafavi-Pour</surname><given-names>Zohreh</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="corresp" rid="cor1">*</xref></contrib><contrib contrib-type="author"><name><surname>Pajouhi</surname><given-names>Naser</given-names></name><xref ref-type="aff" rid="aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Ranjbar Omrani</surname><given-names>Gholam Hossein</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Sepehrimanesh</surname><given-names>Masood</given-names></name><xref ref-type="aff" rid="aff6">6</xref></contrib><contrib contrib-type="author"><name><surname>Zal</surname><given-names>Fatemeh</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="aff" rid="aff8">8</xref></contrib></contrib-group><aff id="aff1"><label>1</label><italic>Endocrine and Metabolism Research Center, Shiraz University of Medical Sciences, Shiraz, Iran;</italic></aff><aff id="aff2"><label>2</label><italic>Razi Herbal Medicines Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran; </italic></aff><aff id="aff3"><label>3</label><italic>Maternal-Fetal Medicine Research Center, Shiraz University of Medical Sciences, Shiraz, Iran; </italic></aff><aff id="aff4"><label>4</label><italic>Recombinant Protein Laboratory, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran;</italic></aff><aff id="aff5"><label>5</label><italic>Department of Physiology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran; </italic></aff><aff id="aff6"><label>6</label><italic>Gastroenterohepatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran; </italic></aff><aff id="aff7"><label>7</label><italic>Reproductive Biology Department, School of Advanced Medical Sciences and Technologies, Shiraz, Iran; </italic></aff><aff id="aff8"><label>8</label><italic>Infertility Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.</italic></aff><author-notes><corresp id="cor1"><label>*</label>Correspondence: Zohreh Mostafavi-Pour. PhD ,Maternal-Fetal Medicine Research Center, Shiraz University of Medical Sciences, Shiraz, Iran and Recombinant Protein Laboratory, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran, E-mail: zmostafavipour88@yahoo.co.uk</corresp></author-notes><pub-date pub-type="ppub"><season>Summer</season><year>2015</year></pub-date><pub-date pub-type="epub"><day>15</day><month>9</month><year>2015</year></pub-date><volume>6</volume><issue>3</issue><fpage>233</fpage><lpage>238</lpage><history><date date-type="received"><day>17</day><month>7</month><year>2014</year></date><date date-type="accepted"><day>8</day><month>12</month><year>2014</year></date></history><permissions><copyright-statement>&#x000a9; 2015 Urmia University. All rights reserved.</copyright-statement><license><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/">http://creativecommons.org/licenses/by/3.0/</ext-link>) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>This work analyzes the effects of <italic>Satureja khuzestanica</italic> essential oil (SKEO) on the thyroid and antioxidant system, assessed by measuring levels of tri-iodothyronine (T3), thyroxine (T4), thyroid-stimulating hormone (TSH), malondialdehyde (MDA), reduced glutathione (GSH), and glutathione peroxidase (GPx) activity. Forty adult male Sprague Dawley rats (225&#x02009;&#x000b1;&#x02009;25 g) were divided into five equal groups: one control and four hyperthyroid groups that received placebo, 200 mg kg<sup>-1</sup> body weight of vitamin (Vit.) E, 225 mg kg<sup>-1 </sup>body weight of SKEO, 200 and 225 mg kg<sup>-1</sup> body weight of Vit. E and SKEO together, respectively. Hyperthyroidism was induced by administering of L-thyroxin in drinking water. After 30 days of L-thyroxin consumption, serum T<sub>3</sub> and T<sub>4</sub> levels, TSH, and oxidative stress indices were determined. Significant increase in serum T<sub>3</sub>, T<sub>4</sub> and MDA concentrations with a simultaneous significant decrease in TSH, GSH level and GPx activity were observed in hyperthyroid group (<italic>p</italic> &#x0003c;0.05). In the treatment groups, SKEO and/or Vit. E can compensate serum MDA elevation and GPx activity reduction. Only, SKEO + Vit. E could compensate the decline of GSH levels in response to hyperthyroidism. Supplementation of SKEO, plus Vit. E as antioxidants is useful in attenuating lipid peroxidation and may potentially benefit hyperthyroid patients.</p></abstract><kwd-group><title>Key Words</title><kwd>Essential oil</kwd><kwd>Experimental hyperthyroidism</kwd><kwd>Glutathione</kwd><kwd>Malondialdehyde</kwd><kwd><italic> Satureja</italic></kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Thyroid hormones have a significant role in regulation of metabolism and increasing the concentration of these hormones in hyperthyroid patients increases the meta-bolism and generates the reactive oxygen species (ROS). These molecules can cause oxidative stress resulting reduced global efficacy of the antioxidant defense system.<sup><xref rid="B1" ref-type="bibr">1</xref></sup> In other words, increased thyroid hormone concentrations affect the oxidant/antioxidant equilibrium and may injure the cells,<sup><xref rid="B2" ref-type="bibr">2</xref></sup> which in the long time, lead to oxidative damage of many organs including the cardiovascular, respiratory and nervous system.<sup><xref rid="B3" ref-type="bibr">3</xref></sup> Treatment with anti-thyroid drugs like propylthiouracil (PTU) cannot restore the balance of the disturbed oxidative and antioxidative activities.<sup><xref rid="B4" ref-type="bibr">4</xref></sup><sup>,</sup><sup><xref rid="B5" ref-type="bibr">5</xref></sup> Thus, controlling the concentration of thyroid hormones and using antioxidants such as vitamins and minerals in hyperthyroid patients for diminishing the related side effects seem vital. The disturbed antioxidant system indicates the possible usefulness of supplementation with antioxidants to preventing the oxidative stress damage in hyperthyroid patients. The beneficial effects of anti-oxidants on oxidative stress induced by hyperthyroidism was shown in several animal models.<sup><xref rid="B6" ref-type="bibr">6</xref></sup><sup>-</sup><sup><xref rid="B8" ref-type="bibr">8</xref></sup> On the other hand, use of herbal medicine for treatment of hyperthyroidism is well known in recent years due to their safety, high efficacy and lower cost.</p><p>
<italic>Satureja khuzestanica</italic> Jamzad (SKJ; Marzeh Khuzestani in Persian, family of Laminaceae) is an endemic plant of southern part of Iran. This plant is a subshrub, branched stem about 30 cm high, densely leafy, and broadly ovaiate-orbicular covered with white hairs. Geographical distribution and shape of this plant are shown in <xref ref-type="fig" rid="F1">Figure 1</xref>. It is used as a folk medicinal plant, because of its therapeutic value as an analgesic and antiseptic properties.<sup><xref rid="B9" ref-type="bibr">9</xref></sup> Active ingredients of <italic>S. khuzestanica</italic> essential oil (SKEO) are carvacol,<sup><xref rid="B10" ref-type="bibr">10</xref></sup> antioxidant <sup><xref rid="B11" ref-type="bibr">11</xref></sup> and flavonoids with anti-oxidant and anti-thyroid properties.<sup><xref rid="B12" ref-type="bibr">12</xref></sup> The SKEO has anti-inflammatory properties,<sup><xref rid="B13" ref-type="bibr">13</xref></sup> ameliorates progression of diabetic nephropathy in uni-nephrectomized diabetic rats<sup><xref rid="B14" ref-type="bibr">14</xref></sup> and improves inflammatory bowel disease by reduction of oxidative stress biomarkers.<sup><xref rid="B15" ref-type="bibr">15</xref></sup> The extract also improves the reproductive potential of normal and cyclophosphamide treated male rats with enhancement of body antioxidant potency.<sup><xref rid="B16" ref-type="bibr">16</xref></sup><sup>,</sup><sup><xref rid="B17" ref-type="bibr">17</xref></sup> However, a recent clinical trial in hyperlipidemic diabetic patients showed that administration of SKEO did not change blood oxidant levels.<sup><xref rid="B18" ref-type="bibr">18</xref></sup> Therefore, the aims of this study were to evaluate the effect of SKEO alone or in combination with vitamin E on hyperthyroid lipid peroxidation (LP), glutathione peroxidase (GPx) activity and its so far unknown ameliorative effects on regulating hyperthyroidism in male rats as a human model. Vitamin E was selected as a potential antioxidant according to the reported effects based on our previous studies.<sup><xref rid="B19" ref-type="bibr">19</xref></sup><sup>,</sup><sup><xref rid="B20" ref-type="bibr">20</xref></sup>
</p><fig id="F1" position="float"><label>Fig. 1</label><caption><p>Geographical distribution of <italic>Satureja khuzestanica </italic>Jamzad in Iran. This plant is densely leafy, and broadly ovaiate-orbicular covered with white hairs</p></caption><graphic xlink:href="vrf-6-233-g001"/></fig></sec><sec sec-type="materials|methods"><title>Materials and Methods</title><p>
<bold>Reagents. </bold>Thiobarbituric acid, tert-butyl hydro-peroxide (t-BuOOH) and 1,1,3,3,-tetraethoxy propane (TEP) were purchased from Sigma Chemical Co. (St Louis, USA). Na<sub>2</sub>-NADPH was obtained from Fluka Chemical Co. (Buchs, St. Gallen, Switzerland). Hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) and sodium azide were obtained from Merck (Darmstadt, Germany). All other chemical reagents were of analytical grades and were supplied by commercial sources.</p><p>
<bold>Plant material and preparation of the essential oil. </bold>The aerial parts of SKJ were collected during the spring season at the flowering stage of the plant from Khoarram-abad (Lorestan province, Iran) and the taxonomic identification of each plant was confirmed by botanist from Department of Botany of the Shiraz University, Shiraz, Iran. A voucher specimen (No. 58416) had been deposited previously at the National Herbarium of Iran, Research Institute of Forests and Rangelands. Preparation of essential oil was performed according to previous reports.<sup><xref rid="B15" ref-type="bibr">15</xref></sup> Briefly, the collected parts of the plant were air-dried at ambient temperature in the shade and hydro-distilled using a Clevenger-type apparatus for 5 hr, giving yellow oil in 0.9% yield. The essence with density of 0.98 was dried over anhydrous sodium sulfate and stored at 4 &#x002da;C.</p><p>
<bold>Animals and housing. </bold>This work was done at the Laboratory Animal Center of Shiraz University of Medical Sciences and was approved by the Ethical Committee of the University. All efforts were made to minimize suffering during the experimental period. Forty male adult Sprague-Dawley rats weighing 225 &#x000b1; 25 g and age of about 14 weeks obtained from the laboratory were used as mature rats in this study. The animals were housed in standard polypropylene cages with wire mesh top and maintained under conventional conditions with 12:12 hr light/dark cycle (lights on at 7:00 A.M.), at an ambient temperature of 22 &#x000b1; 2 &#x002da;C, and 50% relative humidity. The animals had free access to standard laboratory chow and tap water for 10 days before beginning the experimental procedure. Their cages were cleaned every third day and food/water were replenished.</p><p>
<bold>Experimental set-up. </bold>The study comprised five different groups as shown in <xref ref-type="table" rid="T1">Table 1</xref>. The protocol of the study, including doses and duration of treatment, and groups were all designed according to previous studies.<sup><xref rid="B6" ref-type="bibr">6</xref></sup><sup>,</sup><sup><xref rid="B17" ref-type="bibr">17</xref></sup> All animals were treated daily by gavage for 30 days. On the last day, rats were sacrificed by decapitation and blood samples were immediately collected into glass tubes without anticoagulant on ice and were allowed to clot. The blood samples were centrifuged at 700 <italic>g</italic> for 15 min to obtain serum. The clear non-hemolyzed supernatant sera were quickly removed and kept at &#x02013;20 &#x002da;C for further analysis.</p><p>
<bold>Biochemical analysis. </bold>Serum analysis was carried out to measure total Thyroxine (T4) and tri-iodothyronine (T3), by radioimmunoassay (Beckman Coulter, Inc., Fullerton, USA) and TSH by ELISA kit (Cusabio Biotech Co., Newark, USA). The serum malondialdehyde (MDA) was assayed by a colorimetric method as described previously.<sup><xref rid="B20" ref-type="bibr">20</xref></sup> The GPx activity of serum samples was measured by continuous monitoring of the regeneration of GSH from oxidized glutathione, GSSG, upon the action of glutathione reductase and NADPH according to the method of Fecondo and Augusteyn.<sup><xref rid="B21" ref-type="bibr">21</xref></sup> The assay of GSH with DTNB was performed, followed by a standard Ellman&#x02019;s method.<sup><xref rid="B22" ref-type="bibr">22</xref></sup> Briefly, 0.5 mL (0.001 M) of 5,5-dithiobis,2-nitrobenzoic acid (DTNB) (Sigma Aldrich, Darmstadt, Germany) in a PBS was added to all sera and an absorbance of reaction product was observed after 5 min at 412 nm using UV-visible double beam spectro-photometer against a standard curve of GSH.</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Experimental set-up and grouping</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="middle" rowspan="3" colspan="1">
<bold>Group</bold>
</th><th align="center" valign="middle" rowspan="3" colspan="1">
<bold>Thyroid status</bold>
</th><th align="center" valign="middle" colspan="3" rowspan="1">
<bold>Interventions</bold>
<hr/>
</th></tr><tr><th align="center" valign="middle" rowspan="2" colspan="1">
<bold>Hyperthyroidism induction </bold>
<xref ref-type="table-fn" rid="TFN1">a</xref>
</th><th align="center" valign="middle" colspan="2" rowspan="1">
<bold>Treatments</bold>
<hr/>
</th></tr><tr><th align="center" valign="middle" rowspan="1" colspan="1">
<bold>Vitamin E </bold>
<xref ref-type="table-fn" rid="TFN2">b</xref>
</th><th align="center" valign="middle" rowspan="1" colspan="1">
<bold>SKEO </bold>
<xref ref-type="table-fn" rid="TFN3">c</xref>
</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>Negative control </bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Euthyroid</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>Positive control </bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Hyperthyroid</td><td align="center" valign="middle" rowspan="1" colspan="1">+</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>Trial I </bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Hyperthyroid</td><td align="center" valign="middle" rowspan="1" colspan="1">+</td><td align="center" valign="middle" rowspan="1" colspan="1">+</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>Trial II</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Hyperthyroid</td><td align="center" valign="middle" rowspan="1" colspan="1">+</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">+</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>Trial III</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Hyperthyroid</td><td align="center" valign="middle" rowspan="1" colspan="1">+</td><td align="center" valign="middle" rowspan="1" colspan="1">+</td><td align="center" valign="middle" rowspan="1" colspan="1">+</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><label>a</label><p> Hyperthyroidism induced by administering 0.0012% L-thyroxin, (Iran Hormone Co., Tehran, Iran) in drinking water for 30 days. </p></fn><fn id="TFN2"><label>b</label><p> Vitamin E used as dose as 200 mg kg<sup>-1</sup> body weight. </p></fn><fn id="TFN3"><label>c</label><p>
<italic>Satureja khuzestanica</italic> essential oil (SKEO) administered as dose as 225 mg kg<sup>-1</sup> body weight.</p></fn></table-wrap-foot></table-wrap><p>
<bold>Statistical analysis. </bold>All data are presented as mean &#x000b1; standard error of mean (SEM) and analyzed using SPSS (Version 18; SPSS Inc., Chicago, USA) The data were analyzed analyzed by the Kolmogrov - Smirnov test. In this test all data had <italic>p</italic>0.05 and they were considered as parametric data. Therefore, they were subjected to a one way ANOVA followed by Tukey's test. Minimal statistical significance was accepted as <italic>p</italic> &#x0003c; 0.05.</p></sec><sec sec-type="results"><title>Results</title><p>Changes in serum concentrations of T<sub>3</sub>, T<sub>4</sub>, TSH, MDA, GSH and GPx activity in the different groups at the end of the experimental period are presented in <xref ref-type="table" rid="T2">Tables 2</xref> and <xref ref-type="table" rid="T3">3</xref>. A significant increase in serum T<sub>3</sub> and T<sub>4</sub> concentrations and decreased TSH value in all L-thyroxin treated rats were observed. On the other hand, in rats of trials I and III, the intensity of increasing in T<sub>3</sub> value caused by L-thyroxin was lesser compared to other groups (<xref ref-type="table" rid="T2">Table 2</xref>). L-thyroxin treatment caused a significant increase in serum MDA concentration compared to positive control group in all treated rats and consumption of antioxidants alone or in combination restored the serum MDA level to the control one. The effect of SKEO and/or Vit. E on the GPx activity and GSH content of L-thyroxin treated rats are shown in <xref ref-type="table" rid="T3">Table 3</xref>. Although L-thyroxin treatment significantly reduced the GPx activity compared to control group, SKEO or Vit. E feeding (Trial I and II, respectively) restored GPx activity to the level of control group at the end of treatment. In addition, simultaneous use of SKEO and Vit. E (Trial III) increased the GPx activity significantly in comparison to all other groups. Also, GSH content showed significant decline in hyperthyroid against control group. About the GSH content, the most potent treatment was seen when the SKEO and Vit. E used simultaneously. They could significantly compensate the decreasing of GSH in comparison to control group (<xref ref-type="table" rid="T3">Table 3</xref>).</p><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Serum total tri-iodothyronine (T3), thyroxine (T4), and thyroid-stimulating hormone (TSH) concentration (Mean &#x000b1; SEM) in different groups after 30 days treatment (n = 8).</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="middle" rowspan="1" colspan="1">
<bold>Groups</bold>
</th><th align="center" valign="middle" rowspan="1" colspan="1">
<bold>T</bold>
<sub>4</sub>
<bold> (nmol</bold>
<bold>L</bold><sup>-1</sup><bold>)</bold></th><th align="center" valign="middle" rowspan="1" colspan="1">
<bold>T</bold>
<sub>3</sub>
<bold> (nmol</bold>
<bold>L</bold><sup>-1</sup><bold>)</bold></th><th align="center" valign="middle" rowspan="1" colspan="1">
<bold>TSH </bold>
<bold>(&#x000b5;IU mL</bold>
<sup>-1</sup>
<bold>)</bold>
</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>Negative control </bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">3.25 &#x000b1; 0.40<xref ref-type="table-fn" rid="TFN4">a</xref></td><td align="center" valign="middle" rowspan="1" colspan="1">49.00 &#x000b1; 14.56<xref ref-type="table-fn" rid="TFN4">a</xref></td><td align="center" valign="middle" rowspan="1" colspan="1">2.73 &#x000b1; 1.08<xref ref-type="table-fn" rid="TFN4">a</xref></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>Positive control </bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">12.34 &#x000b1; 0.84<xref ref-type="table-fn" rid="TFN4">b</xref></td><td align="center" valign="middle" rowspan="1" colspan="1">226.00 &#x000b1; 69.12<xref ref-type="table-fn" rid="TFN4">b</xref></td><td align="center" valign="middle" rowspan="1" colspan="1">0.07 &#x000b1; 0.07<xref ref-type="table-fn" rid="TFN4">b</xref></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>Trial I </bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">14.24 &#x000b1; 1.51<xref ref-type="table-fn" rid="TFN4">b</xref></td><td align="center" valign="middle" rowspan="1" colspan="1">249.00 &#x000b1; 78.51<xref ref-type="table-fn" rid="TFN4">b</xref></td><td align="center" valign="middle" rowspan="1" colspan="1">ND<xref ref-type="table-fn" rid="TFN5">*</xref></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>Trial II</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">12.32 &#x000b1; 0.88<xref ref-type="table-fn" rid="TFN4">b</xref></td><td align="center" valign="middle" rowspan="1" colspan="1">107.00 &#x000b1; 38.87<xref ref-type="table-fn" rid="TFN4">c</xref></td><td align="center" valign="middle" rowspan="1" colspan="1">0.61 &#x000b1; 0.49<xref ref-type="table-fn" rid="TFN4">b</xref></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>Trial III</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">12.91 &#x000b1; 1.82<xref ref-type="table-fn" rid="TFN4">b</xref></td><td align="center" valign="middle" rowspan="1" colspan="1">109.00 &#x000b1; 55.01<xref ref-type="table-fn" rid="TFN4">c</xref></td><td align="center" valign="middle" rowspan="1" colspan="1">0.09 &#x000b1; 0.09<xref ref-type="table-fn" rid="TFN4">b</xref></td></tr></tbody></table><table-wrap-foot><fn id="TFN4"><label>abc</label><p> Different superscript letters in each column indicate significant differences (<italic>p </italic>&#x0003c; 0.05).</p></fn><fn id="TFN5"><label>*</label><p> ND: Not detectable. </p></fn></table-wrap-foot></table-wrap><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>Serum malondialdehyde (MDA) and reduced glutathione (GSH) concentration with serum glutathione peroxidase (GPx) activity in different groups after 30 days treatment. Data are presented as Mean &#x000b1; SEM (n = 8).</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="middle" rowspan="1" colspan="1">
<bold>Groups</bold>
</th><th align="center" valign="middle" rowspan="1" colspan="1">
<bold>MDA (nmol mL</bold>
<sup>-1</sup>
<bold>)</bold>
</th><th align="center" valign="middle" rowspan="1" colspan="1">
<bold>GPx (U mL</bold>
<sup>-1</sup>
<bold>)</bold>
</th><th align="center" valign="middle" rowspan="1" colspan="1">
<bold>GSH (nmol mL</bold>
<sup>-1</sup>
<bold>)</bold>
</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>Negative control </bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">1.22 &#x000b1; 0.25<xref ref-type="table-fn" rid="TFN6">a</xref></td><td align="center" valign="middle" rowspan="1" colspan="1">131.38 &#x000b1; 2.25<xref ref-type="table-fn" rid="TFN6">a</xref></td><td align="center" valign="middle" rowspan="1" colspan="1">5.16 &#x000b1; 0.39<xref ref-type="table-fn" rid="TFN6">a</xref></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>Positive control </bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">2.80 &#x000b1; 0.28<xref ref-type="table-fn" rid="TFN6">b</xref></td><td align="center" valign="middle" rowspan="1" colspan="1">102.18 &#x000b1; 3.91<xref ref-type="table-fn" rid="TFN6">b</xref></td><td align="center" valign="middle" rowspan="1" colspan="1"> 3.30 &#x000b1; 0.15<xref ref-type="table-fn" rid="TFN6">bc</xref></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>Trial I </bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">1.24 &#x000b1; 0.11<xref ref-type="table-fn" rid="TFN6">a</xref></td><td align="center" valign="middle" rowspan="1" colspan="1">133.33 &#x000b1; 5.80<xref ref-type="table-fn" rid="TFN6">a</xref></td><td align="center" valign="middle" rowspan="1" colspan="1"> 4.45 &#x000b1; 0.28<xref ref-type="table-fn" rid="TFN6">ad</xref></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>Trial II</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">1.12 &#x000b1; 0.16<xref ref-type="table-fn" rid="TFN6">a</xref></td><td align="center" valign="middle" rowspan="1" colspan="1">128.07 &#x000b1; 3.09<xref ref-type="table-fn" rid="TFN6">a</xref></td><td align="center" valign="middle" rowspan="1" colspan="1">4.08 &#x000b1; 0.08<xref ref-type="table-fn" rid="TFN6">bde</xref></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>Trial III</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">1.17 &#x000b1; 0.30<xref ref-type="table-fn" rid="TFN6">a</xref></td><td align="center" valign="middle" rowspan="1" colspan="1">156.75 &#x000b1; 3.55<xref ref-type="table-fn" rid="TFN6">c</xref></td><td align="center" valign="middle" rowspan="1" colspan="1"> 5.01 &#x000b1; 0.42<xref ref-type="table-fn" rid="TFN6">ae</xref></td></tr></tbody></table><table-wrap-foot><fn id="TFN6"><p><bold>abcde:</bold> Different superscript letters in each column indicate significant differences (<italic>p</italic> &#x0003c; 0.05).</p></fn></table-wrap-foot></table-wrap></sec><sec sec-type="discussion"><title>Discussion</title><p>This study provides the assessment of the MDA and GSH levels and also GPx activity changes in hyperthyroid rat in response to SKEO and/or Vit. E consumption. Hyperthyroidism was confirmed by the significant increase of T<sub>4</sub> and T<sub>3</sub> concentration and the decreased level of TSH in all L-thyroxin treated rats. However, in SKEO and SKEO + Vit. E treated rats, the extent of increasing T<sub>3</sub> value caused by L-thyroxin was lesser (about 60%) compared to other hyperthyroid animals. In these groups, serum T<sub>3</sub> concentration was reduced without changes in T<sub>4</sub> level. The T<sub>4</sub> acts as the main source of T<sub>3</sub> production and 87.0% of circulating T<sub>3</sub>, which produced mostly in the liver, is result of T<sub>4</sub> to T<sub>3</sub> conversion by 5' deiodinase enzyme. Flavonoids are potent non-toxic 5' deiodinase inhibitors in microsomal membrane and intact rat hepatocytes.<sup><xref rid="B23" ref-type="bibr">23</xref></sup> The SKEO contains several flavonoids and can decrease T<sub>3</sub> through inhibiting 5' deiodinase activity due to this mechanism.</p><p>In the current study, SKEO and/or Vit. E supplementation normalized elevated serum MDA, as a LP indicator, in hyperthyroid rats. Our finding about antioxidant properties of <italic>S. khuzestanica </italic>Jamzad are in agreement with all other previously researches that reported the antioxidant and anti lipid peroxidation activities of this traditional plant.<sup><xref rid="B18" ref-type="bibr">18</xref></sup><sup>,</sup><sup><xref rid="B24" ref-type="bibr">24</xref></sup><sup>,</sup><sup><xref rid="B25" ref-type="bibr">25</xref></sup> In fact, LP is the automatic chain reactions that produce free radicals in cell membranes and MDA is the most important reactive aldehyde metabolite of free radicals that was produced through LP.<sup><xref rid="B6" ref-type="bibr">6</xref></sup> Hyperthyroidism could induce superoxide generation followed by hydroxyl radicals at the site of ubiquinones that immediately produce free radical-mediated LP, and increases MDA concentration.<sup><xref rid="B26" ref-type="bibr">26</xref></sup> Our data showed that T<sub>3</sub> level in SKEO gavage feeding hyperthyroid animals was markedly decreased suggesting that LP may reduce partly, due to its T<sub>3</sub> level reduction. Carvacrol, the major components of SKEO, acts as a strong antioxidant and can improve the condition of oxidative stress through inhibition of xanthine oxidase, chelation of transition metals, scavenging free radicals, blocking of oxidative reactions and reinforcing of cellular antioxidant capacity.<sup><xref rid="B27" ref-type="bibr">27</xref></sup> Hence, SKEO may reduce LP through carvacrol antioxidant property. Cyclic adenosine monophosphate (cAMP) is a second messenger that controls many key cellular functions. It can diminish oxidative stress in many biological systems and diseases.<sup><xref rid="B28" ref-type="bibr">28</xref></sup> Both cAMP and cGMP elevation that suppress TNF&#x003b1; secretion from peripheral monocytes, macrophages and T cells, can inhibit the production of superoxide anions from neutrophils.<sup><xref rid="B29" ref-type="bibr">29</xref></sup> The only way to inactivate cAMP is to degrade it through the action of cAMP phosphodiesterases (PDEs), a class of enzymes that be able to cleave the phosphodiester bonds in either cAMP or cGMP in order to yield 5&#x02019;-AMP and 5&#x02019;-GMP, respectively. <italic>Satureja</italic> species contain flavonoids that have PDE inhibitory effects an therefore, SKEO may reduce LP due to its PDE inhibition.<sup><xref rid="B30" ref-type="bibr">30</xref></sup>
</p><p>We demonstrated that SKEO or Vit. E gavage feeding increased GPx activity. Combination therapy of both antioxidants could significantly increase the GPx activity compared to the administration of each by itself. SKEO treatment in hyperthyroidism may decrease the workload of GPx and thereby maintaining its activity through the major constituents, carvacrol and flavonoids. Carvacrol scavenging superoxide radicals and hydrogen peroxide with reduction the free-radical-mediated inactivation of enzyme.<sup><xref rid="B31" ref-type="bibr">31</xref></sup> On the other hand, flavonoids are able to donate hydrogen atoms to tocopheryl radicals and therefore recycle antioxidant, like &#x003b1;-tocopherol.<sup><xref rid="B32" ref-type="bibr">32</xref></sup> Thus, a combination of SKEO and Vit. E may be more effective in attenuating oxidative stress induced by hyperthyroidism than either antioxidant used alone. </p><p>To the best of our knowledge, this is the first report on the antioxidant and antithyroid activities of <italic>S. khuzestanica </italic>Jamzad in hyperthyroid rat. In conclusion, we have described the usefulness of this plant in attenuating LP in the hyperthyroid rats which in turn may potentially beneficial in hyperthyroid patients. Further pharmacological and toxicological study may be warranted to establish any potential therapeutic use of this plant and its active compounds. </p></sec></body><back><ack><title>Acknowledgments</title><p>This study was supported by grant No. 3072 from the office of Vice Chancellor for Research and Metabolism and Endocrine Research Center of Shiraz University of Medical Sciences Shiraz, Iran. Animals were kindly provided by Dr. Mahjoob Vahedi at the Laboratory Animal Center of University of Medical Science, Shiraz, Iran. </p></ack><ref-list><title>References</title><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Venditti</surname><given-names>P</given-names></name><name><surname>di</surname><given-names>Stefano L</given-names></name><name><surname>di</surname><given-names>Meo S</given-names></name></person-group><article-title>Vitamin E management of oxidative damage-linked dysfunctions of hyperthyroid tissues</article-title><source> Cell Mol Life Sci</source><year>2013</year><volume>70</volume><issue>17</issue><fpage>3125</fpage><lpage>3144</lpage><pub-id pub-id-type="pmid">23255045</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yucel</surname><given-names>R</given-names></name><name><surname>Ozdemir</surname><given-names>S</given-names></name><name><surname>Dariyerli</surname><given-names>N</given-names></name><etal/></person-group><article-title>Erythrocyte osmotic fragility and lipid peroxidation in experimental hyperthyroidism</article-title><source> Endocrine</source><year>2009</year><volume>36</volume><issue>3</issue><fpage>498</fpage><lpage>502</lpage><pub-id pub-id-type="pmid">19851894</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meng</surname><given-names>Z</given-names></name><name><surname>Qin</surname><given-names>G</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><etal/></person-group><article-title>DNA damaging effects of sulfur dioxide derivatives in cells from various organs of mice</article-title><source> Mutagenesis</source><year>2004</year><volume>19</volume><issue>6</issue><fpage>465</fpage><lpage>468</lpage><pub-id pub-id-type="pmid">15548758</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panda</surname><given-names>S</given-names></name><name><surname>Kar</surname><given-names>A</given-names></name></person-group><article-title>Evaluation of the antithyroid, anti-oxidative and antihyperglycemic activity of scopoletin from Aegle marmelos leaves in hyperthyroid rats</article-title><source> Phytother Res</source><year>2006</year><volume>20</volume><issue>12</issue><fpage>1103</fpage><lpage>1105</lpage><pub-id pub-id-type="pmid">17078113</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ozdem</surname><given-names>S</given-names></name><name><surname>Aliciguzel</surname><given-names>Y</given-names></name><name><surname>Ozdem</surname><given-names>SS</given-names></name><etal/></person-group><article-title>Effects of propylthiouracil treatment on antioxidant activities in blood of toxic multinodular goiter patients</article-title><source> Pharmacology</source><year>2000</year><volume>61</volume><issue>1</issue><fpage>31</fpage><lpage>36</lpage><pub-id pub-id-type="pmid">10895078</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Subudhi</surname><given-names>U</given-names></name><name><surname>Das</surname><given-names>K</given-names></name><name><surname>Paital</surname><given-names>B</given-names></name><etal/></person-group><article-title>Alleviation of enhanced oxidative stress and oxygen consumption of L-thyroxine induced hyperthyroid rat liver mitochondria by vitamin E and curcumin</article-title><source> Chem Biol Interact</source><year>2008</year><volume>173</volume><issue>2</issue><fpage>105</fpage><lpage>114</lpage><pub-id pub-id-type="pmid">18377885</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Subudhi</surname><given-names>U</given-names></name><name><surname>Chainy</surname><given-names>GB</given-names></name></person-group><article-title>Expression of hepatic anti-oxidant genes in L-thyroxine-induced hyperthyroid rats: regulation by vitamin E and curcumin</article-title><source> Chem Biol Interact</source><year>2010</year><volume>183</volume><issue>2</issue><fpage>304</fpage><lpage>316</lpage><pub-id pub-id-type="pmid">19914224</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panda</surname><given-names>S</given-names></name><name><surname>Kar</surname><given-names>A</given-names></name></person-group><article-title>Amelioration of L-thyroxine-induced hyperthyroidism by coumarin (1,2-benzopyrone) in female rats</article-title><source> Clin Exp Pharmacol Physiol</source><year>2007</year><volume>34</volume><issue>11</issue><fpage>1217</fpage><lpage>1219</lpage><pub-id pub-id-type="pmid">17880380</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Zargari</surname><given-names>A</given-names></name></person-group><source>Medicinal plants</source><year>1990</year><edition>4th ed</edition><publisher-loc>Tehran, Iran</publisher-loc><publisher-name>University of Tehran Press</publisher-name><fpage>68</fpage></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hadian</surname><given-names>J</given-names></name><name><surname>Akramian</surname><given-names>M</given-names></name><name><surname>Heydari</surname><given-names>H</given-names></name><etal/></person-group><article-title>Composition and in vitro antibacterial activity of essential oils from four Satureja species growing in Iran</article-title><source> Nat Prod Res</source><year>2012</year><volume>26</volume><issue>2</issue><fpage>98</fpage><lpage>108</lpage><pub-id pub-id-type="pmid">21827283</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>D</given-names></name><name><surname>Rawat</surname><given-names>DS</given-names></name></person-group><article-title>Synthesis and antioxidant activity of thymol and carvacrol based Schiff bases</article-title><source> Bioorg Med Chem Lett</source><year>2013</year><volume>23</volume><issue>3</issue><fpage>641</fpage><lpage>645</lpage><pub-id pub-id-type="pmid">23273412</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de</surname><given-names>Souza Dos Santos MC</given-names></name><name><surname>Goncalves</surname><given-names>CF</given-names></name><name><surname>Vaisman</surname><given-names>M et al</given-names></name></person-group><article-title>Impact of flavonoids on thyroid function</article-title><source> Food Chem Toxicol</source><year>2011</year><volume>49</volume><issue>10</issue><fpage>2495</fpage><lpage>2502</lpage><pub-id pub-id-type="pmid">21745527</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amanlou</surname><given-names>M</given-names></name><name><surname>Dadkhah</surname><given-names>F</given-names></name><name><surname>Salehnia</surname><given-names>A</given-names></name><etal/></person-group><article-title>An anti-inflammatory and anti-nociceptive effects of hydro-alcoholic extract of Satureja khuzistanica Jamzad extract</article-title><source> J Pharm Pharm Sci</source><year>2005</year><volume>8</volume><issue>1</issue><fpage>102</fpage><lpage>106</lpage><pub-id pub-id-type="pmid">15946603</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tavafi</surname><given-names>M</given-names></name><name><surname>Ahmadvand</surname><given-names>H</given-names></name><name><surname>Tamjidipoor</surname><given-names>A</given-names></name><etal/></person-group><article-title>Satureja khozestanica essential oil ameliorates progression of diabetic nephropathy in uninephrectomized diabetic rats</article-title><source> Tissue Cell</source><year>2011</year><volume>43</volume><issue>1</issue><fpage>45</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">21185580</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghazanfari</surname><given-names>G</given-names></name><name><surname>Minaie</surname><given-names>B</given-names></name><name><surname>Yasa</surname><given-names>N</given-names></name><etal/></person-group><article-title>Biochemical and histopathological evidences for beneficial effects of Satureja khuzestanica Jamzad essential oil on the mouse model of inflammatory bowel diseases</article-title><source> Toxicol Mech Meth</source><year>2006</year><volume>16</volume><issue>7</issue><fpage>365</fpage><lpage>372</lpage></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haeri</surname><given-names>S</given-names></name><name><surname>Minaie</surname><given-names>B</given-names></name><name><surname>Amin</surname><given-names>G</given-names></name><etal/></person-group><article-title>Effect of Satureja khuzestanica essential oil on male rat fertility</article-title><source> Fitoterapia</source><year>2006</year><volume>77</volume><issue>7</issue><fpage>495</fpage><lpage>499</lpage><pub-id pub-id-type="pmid">16889906</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rezvanfar</surname><given-names>M</given-names></name><name><surname>Sadrkhanlou</surname><given-names>R</given-names></name><name><surname>Ahmadi</surname><given-names>A</given-names></name><etal/></person-group><article-title>Protection of cyclophosphamide-induced toxicity in reproductive tract histology, sperm characteristics, and DNA damage by an herbal source; evidence for role of free-radical toxic stress</article-title><source> Hum Exp Toxicol</source><year>2008</year><volume>27</volume><issue>12</issue><fpage>901</fpage><lpage>910</lpage><pub-id pub-id-type="pmid">19273545</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vosough-Ghanbari</surname><given-names>S</given-names></name><name><surname>Rahimi</surname><given-names>R</given-names></name><name><surname>Kharabaf</surname><given-names>S</given-names></name><etal/></person-group><article-title>Effects of Satureja khuzestanica on serum glucose, lipids and markers of oxidative stress in patients with type 2 diabetes mellitus: a double-blind randomized controlled trial</article-title><source> Evid Based Complement Alternat Med</source><year>2010</year><volume>7</volume><issue>4</issue><fpage>465</fpage><lpage>470</lpage><pub-id pub-id-type="pmid">18955324</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mostafavi-Pour</surname><given-names>Z</given-names></name><name><surname>Zal</surname><given-names>F</given-names></name><name><surname>Monabati</surname><given-names>A</given-names></name><etal/></person-group><article-title>Protective effects of a combination of quercetin and vitamin E against cyclosporine A-induced oxidative stress and hepatotoxicity in rats</article-title><source> Hepatol Res</source><year>2008</year><volume>38</volume><issue>4</issue><fpage>385</fpage><lpage>392</lpage><pub-id pub-id-type="pmid">17927767</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zal</surname><given-names>F</given-names></name><name><surname>Mostafavi-Pour</surname><given-names>Z</given-names></name><name><surname>Vessal</surname><given-names>M</given-names></name></person-group><article-title>Comparison of the effects of vitamin E and/or quercetin in attenuating chronic cyclosporine A-induced nephrotoxicity in male rats</article-title><source> Clin Exp Pharmacol Physiol</source><year>2007</year><volume>34</volume><issue>8</issue><fpage>720</fpage><lpage>724</lpage><pub-id pub-id-type="pmid">17600547</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fecondo</surname><given-names>JV</given-names></name><name><surname>Augusteyn</surname><given-names>RC</given-names></name></person-group><article-title>Superoxide dismutase, catalase and glutathione peroxidase in the human cataractous lens</article-title><source> Exp Eye Res</source><year>1983</year><volume>36</volume><issue>1</issue><fpage>15</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">6825728</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tietze</surname><given-names>F</given-names></name></person-group><article-title>Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues</article-title><source> Anal Biochem</source><year>1969</year><volume>27</volume><issue>3</issue><fpage>502</fpage><lpage>522</lpage><pub-id pub-id-type="pmid">4388022</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spanka</surname><given-names>M</given-names></name><name><surname>Koehrle</surname><given-names>J</given-names></name><name><surname>Irmscher</surname><given-names>K</given-names></name><etal/></person-group><article-title>Flavonoids specifically inhibit iodothyronine-deiodinase in rat hepatocytes</article-title><source> Prog Clin Biol Res</source><year>1988</year><volume>280</volume><fpage>341</fpage><lpage>344</lpage><pub-id pub-id-type="pmid">3262876</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saei-Dehkordi</surname><given-names>S</given-names></name><name><surname>Fallah</surname><given-names>AA</given-names></name><name><surname>Heidari-Nasirabadi</surname><given-names>M</given-names></name><etal/></person-group><article-title>Chemical composition, antioxidative capacity and interactive antimicrobial potency of Satureja khuzestanica Jamzad essential oil and antimicrobial agents against selected food-related microorganisms</article-title><source> Int J Food Sci Technol</source><year>2012</year><volume>47</volume><issue>8</issue><fpage>1579</fpage><lpage>1585</lpage></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdollahi</surname><given-names>M</given-names></name><name><surname>Salehnia</surname><given-names>A</given-names></name><name><surname>Mortazavi</surname><given-names>S</given-names></name><etal/></person-group><article-title>Antioxidant, antidiabetic, antihyperlipidemic, reproduction stimulatory properties and safety of essential oil of Satureja Khuzestanica in rat in vivo: A toxicopharma-cological study</article-title><source> Med Sci Monit</source><year>2003</year><volume>9</volume><issue>9</issue><fpage>331</fpage><lpage>335</lpage></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Venditti</surname><given-names>P</given-names></name><name><surname>De</surname><given-names>Rosa R</given-names></name><name><surname>Di</surname><given-names>Meo S</given-names></name></person-group><article-title>Effect of thyroid state on H2O2 production by rat liver mitochondria</article-title><source> Mol Cell Endocrinol</source><year>2003</year><volume>205</volume><issue>1</issue><fpage>185</fpage><lpage>192</lpage><pub-id pub-id-type="pmid">12890580</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oliveira</surname><given-names>IS</given-names></name><name><surname>da</surname><given-names>Silva FV</given-names></name><name><surname>Viana</surname><given-names>AF</given-names></name><etal/></person-group><article-title>Gastroprotective activity of carvacrol on experimentally induced gastric lesions in rodents</article-title><source> Naunyn Schmiedebergs Arch Pharmacol</source><year>2012</year><volume>385</volume><issue>9</issue><fpage>899</fpage><lpage>908</lpage><pub-id pub-id-type="pmid">22739789</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Kuro-o</surname><given-names>M</given-names></name><name><surname>Sun</surname><given-names>Z</given-names></name></person-group><article-title>Klotho gene delivery suppresses Nox2 expression and attenuates oxidative stress in rat aortic smooth muscle cells via the cAMP-PKA pathway</article-title><source> Aging Cell</source><year>2012</year><volume>11</volume><issue>3</issue><fpage>410</fpage><lpage>417</lpage><pub-id pub-id-type="pmid">22260450</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vezzosi</surname><given-names>D</given-names></name><name><surname>Bertherat</surname><given-names>J</given-names></name></person-group><article-title>Phosphodiesterases in endocrine physiology and disease</article-title><source> Eur J Endocrinol</source><year>2011</year><volume>165</volume><issue>2</issue><fpage>177</fpage><lpage>188</lpage><pub-id pub-id-type="pmid">21602319</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rahimi</surname><given-names>R</given-names></name><name><surname>Ghiasi</surname><given-names>S</given-names></name><name><surname>Azimi</surname><given-names>H</given-names></name><etal/></person-group><article-title>A review of the herbal phosphodiesterase inhibitors; future perspective of new drugs</article-title><source> Cytokine</source><year>2010</year><volume>49</volume><issue>2</issue><fpage>123</fpage><lpage>129</lpage><pub-id pub-id-type="pmid">20005737</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jayakumar</surname><given-names>S</given-names></name><name><surname>Madankumar</surname><given-names>A</given-names></name><name><surname>Asokkumar</surname><given-names>S</given-names></name><etal/></person-group><article-title>Potential preventive effect of carvacrol against diethyl-nitrosamine-induced hepatocellular carcinoma in rats</article-title><source> Mol Cel Biochem</source><year>2012</year><volume>360</volume><issue>1-2</issue><fpage>51</fpage><lpage>60</lpage></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woldu</surname><given-names>AS</given-names></name><name><surname>Mai</surname><given-names>J</given-names></name></person-group><article-title>A novel relationship between the radical-scavenging activity of flavonoids and enthalpy of formation revealed with Hartree-Fock computations and thermochemical deduction</article-title><source> Redox Report</source><year>2012</year><volume>17</volume><issue>3</issue><fpage>115</fpage><lpage>130</lpage><pub-id pub-id-type="pmid">22732939</pub-id></element-citation></ref></ref-list></back></article>